PRF1 and neoplasm: However, the effector activity of CD4+ T cells may be subject to its differentiation stages in response to M002 treatment and the tumor microenvironmental cues, which requires future exploration, given that the increased GzmB (also perforin) expression was observed early after M002 treatment and upon in vitro and in vivo recall responses.